Dr. David Y Oh, MD, PhD

Claim this profile

University of California, San Francisco

Studies Prostate Cancer
Studies Prostate Adenocarcinoma
3 reported clinical trials
10 drugs studied

Affiliated Hospitals

Image of trial facility.
University Of California, San Francisco

Clinical Trials David Y Oh, MD, PhD is currently running

Image of trial facility.

Pembrolizumab +/− Axitinib

for Renal Cell Carcinoma

This phase II trial studies how well pembrolizumab with or without standard of care axitinib works in treating patients with clear cell kidney cancer that has spread to nearby tissues or lymph nodes (locally advanced) or other places in the body (metastatic) who are undergoing surgery. Pembrolizumab is an antibody that is designed to bind to and block the activity of PD-1, a molecule in the body that may be responsible for inhibiting the body's immune response against cancer cells. Axitinib is a type of drug known as a tyrosine kinase inhibitor. Tyrosine kinase inhibitors work by blocking enzymes called tyrosine kinases. These enzymes may be too active or found at high levels in some types of cancer cells and blocking them may help keep cancer cells from growing. Giving pembrolizumab with or without axitinib may work better in controlling the cancer and decrease the likelihood of it coming back following surgery in patients with kidney cancer compared to usual treatment (surgery followed by chemotherapy and/or radiation therapy).
Recruiting1 award Phase 211 criteria

More about David Y Oh, MD, PhD

Clinical Trial Related5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments David Y Oh, MD, PhD has experience with
  • Pembrolizumab
  • Leuprolide Acetate
  • Prednisone
  • SD-101
  • Atezolizumab
  • Etrumadenant
Breakdown of trials David Y Oh, MD, PhD has run
Prostate Cancer
Prostate Adenocarcinoma
Skin Cancer
Renal Cell Carcinoma
Kidney Cancer

Other Doctors you might be interested in

Sabine Mueller, MD, PhD, MASUniversity of California, San Francisco
Sue S. YomUniversity of California San Francisco
Thomas Martin, MDUniversity Of California San Francisco Medical Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Y Oh, MD, PhD specialize in?
David Y Oh, MD, PhD focuses on Prostate Cancer and Prostate Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is David Y Oh, MD, PhD currently recruiting for clinical trials?
Yes, David Y Oh, MD, PhD is currently recruiting for 1 clinical trial in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that David Y Oh, MD, PhD has studied deeply?
Yes, David Y Oh, MD, PhD has studied treatments such as Pembrolizumab, Leuprolide acetate, Prednisone.
What is the best way to schedule an appointment with David Y Oh, MD, PhD?
Apply for one of the trials that David Y Oh, MD, PhD is conducting.
What is the office address of David Y Oh, MD, PhD?
The office of David Y Oh, MD, PhD is located at: University of California, San Francisco, San Francisco, California 94143 United States. This is the address for their practice at the University of California, San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top